why choose us

Clinical Trials Search

Showing 19,930 of 132,963 result(s)
Development of The Pediatric Physical Activity Tracking Platform (Pedi@Ctivity) and Smartwatch-based Big Data Analysis

Status: Completed

Condition: Physical Activity

Interventions: "Pedi@ctivity Analysis Mobile Application" and than Pedi@ctivity Analysis and Tracking Web Platform synchronized with the Pedi@ctivity Track

Date: 2022-08-19

Plerixafor for Poorly Mobilized Lymphoma

Status: Completed

Condition: Lymphoma

Interventions:

G-CSF: 10 ?g;kg;day, subcutaneously injected, every morning from day 1 to day 8.

Plerixafor injection: 0.24 mg;kg;day, su

Date: 2022-08-19

Pain and Activity Levels After Orthodontic Separators

Status: COMPLETED

Condition: Dental Malocclusion

Interventions: Elastomeric separators will be placed on the mesial and distal of lower first permanent molars for a total of four separators per subject.
Subjec

Date: 2022-08-19

A Survey of Icatibant in Pediatric Participants With Hereditary Angioedema

Status: COMPLETED

Condition: Hereditary Angioedema (HAE)

Interventions: Icatibant, 10 to 30 mg, Subcutaneous injection

Date: 2022-08-19

Navitoclax in Relapsed or Refractory High-Risk Myelodysplastic Syndrome

Status: COMPLETED

Condition: Myelodysplastic Syndrome
Recurrent Myelodysplastic Syndrome
Refractory Myelodysplastic Syn

Interventions: BIOLOGICAL: Navitoclax - Given PO
DRUG: Venetoclax - Given PO
DRUG: Decitabine - Given IV
PROCEDURE: Bone Marrow Biopsy - Undergo bone

Date: 2022-08-19

TMS for PTSD and Blood Pressure

Status: COMPLETED

Condition: Post-traumatic Stress Disorder
Hypertension

Interventions: DEVICE: Transcranial magnetic stimulation - Participants will undergo a standard course of TMS treatment (30 sessions/6 weeks).

Date: 2022-08-19

Monopolar Versus Biopolar Radiofrequency in OA Knee Pain

Status: COMPLETED

Condition: Osteoarthritis, Knee

Interventions: In monopolar group : .
Inferomedial, superomedial, and superolateral GN branches of the patients were identified with ultrasonography, and a 22 G

Date: 2022-08-18

A Study of Coformulated Favezelimab;Pembrolizumab (MK-4280A) Versus Physician's Choice Chemotherapy in PD-(L)1-refractory, Relapsed or Refractory Classical Hodgkin Lymphoma (MK-4280A-008)

Status: COMPLETED

Condition: Hodgkin Lymphoma

Interventions: Coformulated favezelimab;pembrolizumab (800 mg;200 mg), IV infusion

Date: 2022-08-18

Split-belt Treadmill Training for Freezing of Gait in Parkinson's Disease

Status: COMPLETED

Condition: Parkinson Disease

Interventions: Split-belt walking with various speed ratios between the two legs, applied with random-block practice

Date: 2022-08-18